Blockchain Registration Transaction Record

Common Thyroid Hormone Shows Promise in Pediatric Brain Tumor Fight

Research shows combining thyroid hormone T3 with chemotherapy may prevent pediatric brain tumor recurrence. Learn about CNS Pharmaceuticals and TinyGems coverage.

This news matters because it identifies a potential low-cost, readily available treatment option that could significantly improve outcomes for children with brain tumors. Repurposing a commonly used thyroid hormone could accelerate the development of more effective therapies, reduce recurrence rates, and offer hope to families facing this devastating diagnosis. The study also underscores the value of drug repurposing and the need for continued research into innovative combinations.